Q3 FY2026 · ended Jun 30, 2026 · Revenue $10,000 · Filed Aug 14, 2026
Bodhi Tree Biotechnology Inc. (BDTB) files with the SEC under industry code 8742, Services-Management Consulting Services. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $10,000 and a net loss of $23,194.
Revenue
$10,000
Net income
$-23,194
-11.6% vs year-ago quarter
Operating cash flow
$-18,764
+23.9% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
25.44M
+0.0% vs year-ago quarter
Net cash
—
Operating margin
-310.2%
TTM
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- BDTB (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2041531
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- Astrana Health, Inc. ASTH
- ICF International, Inc. ICFI
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $10,000 | $15,000 | $0 | $12,000 | $0 |
| Operating income | -$23,195 | -$27,934 | -$52,949 | -$10,687 | -$19,975 |
| Net income | -$23,194 | -$29,196 | -$52,948 | -$10,687 | -$20,774 |
| Diluted EPS | $0.00 | $0.00 | -$0.01 | -$0.00 | $0.00 |
| Operating cash flow | -$18,764 | -$24,616 | -$62,038 | -$10,112 | -$24,649 |
| Total assets | $18,323 | $40,517 | $69,713 | $119,161 | $129,848 |
| Total liabilities | $4,500 | $3,500 | $3,500 | — | — |
| Stockholders' equity | $13,823 | $37,017 | $66,213 | $119,161 | $129,848 |
| Cash and investments | $3,986 | $22,750 | $47,366 | $109,404 | $119,516 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Jul 28, 2025 | Mar 31, 2025 |
All 26 Bodhi Tree Biotechnology Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.